UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of Registrant as Specified in its Charter)
|
|
|
|
|
|
|
|
|
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
|
|
|
|
|
(Address of principal executive offices) |
|
(Zip Code) |
Registrant’s Telephone Number, Including Area Code: (
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
|
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
|
|
|
|
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 1.01 Entry into a Material Definitive Agreement.
On September 29, 2022 (the “Grant Date”), following the re-election of directors at the 2022 annual meeting of stockholders of Marchex, Inc. (“Marchex”), Marchex granted each of Marchex’s directors (i) 15,000 restricted shares of Class B common stock at a purchase price of $.01 per share; and (ii) 20,000 options at an exercise price of $1.78 per share, the exercise price being the closing price of Marchex’s stock on the Grant Date, in each case under Marchex’s 2021 Stock Incentive Plan as compensation for their annual board service. Fifty percent (50%) of such shares of restricted stock and options shall vest on the first and second annual anniversaries of the Grant Date, respectively, and with vesting in full upon a Change in Control (as defined in such restricted stock and option agreements), in each case assuming continued service on Marchex’s Board of Directors for such period. In addition, Marchex agreed to pay each non-employee director $7,500 in cash per quarter for the independent directors’ annual board service.
Item 5.07 Submission of Matters to a Vote of Security Holders.
Annual Meeting of Stockholders
On September 29, 2022, Marchex held its 2022 annual meeting of stockholders (the “Annual Meeting”). Holders of Class A common stock are entitled to twenty-five (25) votes per share and holders of Class B common stock are entitled to one (1) vote per share and vote together as a single class on all matters (including election of directors) submitted to a vote of stockholders, unless otherwise required by law. At the Annual Meeting, the stockholders elected each director nominee to the Board of Directors by the following votes as certified by Computershare, Inc., Marchex’s transfer agent, as tabulator (“Computershare”):
|
|
|
|
|
|
|
Nominee |
|
For |
|
Withheld |
|
Dennis Cline |
|
141,064,625 |
|
3,033,073 |
|
Donald Cogsville |
|
142,933,402 |
|
1,164,296 |
|
Russell C. Horowitz |
|
143,522,440 |
|
575,258 |
|
M. Wayne Wisehart |
|
142,921,558 |
|
1,176,140 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, Marchex has duly caused this Current Report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
MARCHEX, INC. |
|
|
|
|
|
|
Date: October 3, 2022 |
By: |
/s/ MICHAEL A. ARENDS |
|
|
Name: |
Michael A. Arends |
|
|
Title: |
Co-CEO (Principal Executive Officer for SEC reporting purposes) |
Document and Entity Information |
Sep. 29, 2022 |
|---|---|
| Cover [Abstract] | |
| Document Type | 8-K |
| Amendment Flag | false |
| Document Period End Date | Sep. 29, 2022 |
| Entity Registrant Name | Marchex, Inc. |
| Entity Central Index Key | 0001224133 |
| Entity Emerging Growth Company | false |
| Entity File Number | 000-50658 |
| Entity Incorporation, State or Country Code | DE |
| Entity Tax Identification Number | 35-2194038 |
| Entity Address, Address Line One | 520 Pike Street |
| Entity Address, Address Line Two | Suite 2000 |
| Entity Address, City or Town | Seattle |
| Entity Address, State or Province | WA |
| Entity Address, Postal Zip Code | 98101 |
| City Area Code | 206 |
| Local Phone Number | 331-3300 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Class B Common Stock, par value $0.01 per share |
| Trading Symbol | MCHX |
| Security Exchange Name | NASDAQ |
-8?20$3;
M8T.P6BP^0"X99K>]9!:G